🔎 Trials Near Me

Home › T-Cell Lymphoma › Washington › Seattle

T-Cell Lymphoma clinical trials in Seattle, WA

6 studies for T-Cell Lymphoma are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

RecruitingPhase 3
  • University of Washington Fred Hutch Cancer Center, Seattle
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06561048

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

RecruitingPhase 3
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
Ages 18 to 75 · All sexes · Updated Sep 14, 2026 · NCT06724237

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

RecruitingPhase 2
  • Fred Hutchinson Cancer Center, Seattle
  • University of Washington Medical Center - Montlake, Seattle
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT04803201

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

RecruitingPhase 1/2
  • Swedish Cancer Institute, Seattle
  • Fred Hutchinson Cancer Center, Seattle
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT04104776

Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

RecruitingPhase 1/2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Ages 18 and older · All sexes · Updated May 11, 2026 · NCT07225985

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RecruitingPhase 1
  • Seattle Children's Hospital, Seattle
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770

T-Cell Lymphoma trials in other cities

Other studies in Seattle

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.